Sign up
Research trends

What urology is researching now

The topics gaining the most ground, ranked by the PubDaily Trend Score: new research, stronger evidence, new trials and new guidelines. 291 topics in 22 specialties, updated 18 Oct 2026.

Monthly reportThe fastest-rising topics in medicine: October 2026Read →
12 topics · urology

Minimally invasive BPH treatments

Rising
+36%new papersScore 69
20212026

Water vapour therapy, urethral lift, aquablation and prostatic artery embolisation.

183 papers / yr16 new trials4 new guidelines
See all papers →

Antibody-drug conjugates in bladder cancer

Rising
+40%new papersScore 62
20212026

Enfortumab vedotin and other ADCs in urothelial cancer.

Key point: Enfortumab vedotin-related adverse events, particularly cutaneous toxicity, were associated with favorable clinical outcomes, but findings are hypothesis-generating and need prospective confirmation.

446 papers / yr44 new trials2 new guidelines
See all papers →

MRI in prostate cancer diagnosis

Rising
+18%new papersScore 57
20212026

MRI before biopsy and in screening for prostate cancer.

951 papers / yr81 new trials4 new guidelines
See all papers →

Transperineal prostate biopsy

Steady
+13%new papersScore 51
20212026

Biopsy through the perineum instead of the rectum.

Key point: Transperineal biopsy is the recommended approach when technically feasible.

217 papers / yr19 new trials3 new guidelines
See all papers →

Thulium fibre laser

Steady
+8%new papersScore 50
20212026

Thulium fibre laser for stone lithotripsy and prostate surgery.

Key point: ThuFLEP and conventional HoLEP are clinically comparable, with no definitive superiority of either laser.

111 papers / yr15 new trials
See all papers →

PSMA PET in prostate cancer

Steady
+15%new papersScore 47
20212026

PSMA PET imaging for staging and recurrence of prostate cancer.

Key point: PSMA-PET/CT is recommended only when PSA exceeds 0.2 μg/L, reporting should follow PSMA-RADS, and it is preferred over lymph-node dissection for staging.

948 papers / yr102 new trials2 new guidelines
See all papers →

See all 12 urology topics

Every rising topic, with the papers behind it. Free for doctors.

How the Trend Score works

Four signals

Growth in new papers (35%), growth in randomised trials, meta-analyses and systematic reviews (25%), new clinical trials registered (20%), and new guidelines and consensus statements (20%), each over the last 12 months against the 12 before.

A score out of 100

Each signal is ranked against every topic we follow, so a score of 90 means the topic is ahead of about 90% of them. Rising fast: 80 and above. Rising: 55 to 79. Emerging: fewer than 100 papers the year before, too few to rank.

What it does not tell you

More research on a topic is not evidence that a treatment works. Open a topic to read the papers and guidelines themselves. Counts come from PubMed and ClinicalTrials.gov.